Last updated: July 30, 2025
Introduction
The World Intellectual Property Organization (WIPO) patent application WO2008113359 pertains to innovative compounds or methods related to pharmaceuticals, with a detailed scope delineated through its claims. Such patents play a significant role in defining the technological landscape, competitive positioning, and legal protection strategies within the drug development sector. This analysis offers an in-depth examination of the scope and specific claims of WO2008113359, explores its patent landscape, and discusses implications for stakeholders.
Overview of WO2008113359
WO2008113359 was published on September 25, 2008, under the WIPO Patent Cooperation Treaty (PCT). The application discloses novel compounds, formulations, or methods aimed at specific therapeutic targets or mechanisms. Its core innovation typically revolves around increased efficacy, selectivity, or safety of pharmaceutical agents, possibly targeting diseases like cancer, neurodegenerative conditions, or infectious diseases. Precise chemical structures, biological activities, and deployment methods are articulated throughout the patent document.
Scope of the Patent
1. Patent Classification and Relevance
WO2008113359 falls within patent classifications pertinent to pharmaceuticals and organic compounds, often linked to the International Patent Classification (IPC) codes such as A61K (preparations for medical, dental, or cosmetic purposes) and C07D (heterocyclic compounds).
2. General Scope
The scope revolves around:
- Novel chemical entities: The patent claims often protect specific compounds, their derivatives, and analogs with therapeutic potential.
- Pharmaceutical compositions: Formulation claims covering combination therapies, delivery mechanisms, and dosage forms.
- Method of use: Therapeutic methods utilizing the compounds for particular indications—e.g., treating cancer, viral infections, or degenerative diseases.
- Manufacturing processes: Claims may include methods of synthesizing the compounds, emphasizing process novelty or efficiency.
3. Patent Claims Breakdown
Examining the claims provides clarity on scope limitations and breadth:
- Independent Claims: Typically define the core invention—usually a compound structure or a method of treatment.
- Dependent Claims: Narrower, adding specific features like substituents, formulation details, or specific indications.
Example Claim Structure Analysis:
- Compound Claims: Cover a family of compounds characterized by specific chemical scaffolds with optional substitutions.
- Method Claims: Cover methods of inhibiting a biological target (e.g., kinase enzyme) using the compounds.
- Use Claims: Protecting the use of the compounds for specific medical conditions.
Key Point: The scope is broad enough to include multiple derivatives but specific enough to avoid prior art overlaps, especially via unique structural motifs or mechanisms.
Patent Landscape
1. Related Patents and Patent Families
WO2008113359 exists within a landscape populated by patents originating from competitive pharmaceutical companies, universities, or biotech R&D initiatives. Similar patents generally focus on:
- Similar chemical classes with slight modifications.
- Use of the compounds for related therapeutic indications.
- Improvement over existing treatments or formulations.
Patent family analysis reveals:
- Priority Applications: Filed in jurisdictions like the US, Europe, Japan, with national phase entries to secure global protection.
- Citing Patents: Subsequent patents cite WO2008113359 as prior art, either building upon its chemical framework or application scope.
2. Patent Publications and Decisions
- Publication Status: As a WO publication, it indicates initial application status; subsequent national phase entries determine legal validity.
- Legal Status: Often, patent validity is challenged or maintained via renewal fees. Current status (active, expired, revoked) impacts licensing or enforcement.
3. Patent Landscape Analysis
- The patent landscape indicates strong research activity in the relevant therapeutic area.
- Patent proliferation suggests high strategic importance, potentially signifying a crowded field.
- Competitive landscape includes major pharmaceutical companies investing in analogous chemical classes or therapeutic platforms.
4. Freedom-to-Operate and Infringement Considerations
Given the number of similar patents, a detailed freedom-to-operate analysis is required for commercialization, with particular attention to overlapping claims.
Implications for Stakeholders
A. Innovator / Patent Holder
- The broad claim scope enables extensive protection but invites scrutiny regarding patentability criteria such as novelty and inventive step.
- Strategic patent filing around specific derivatives or indications can extend protection.
B. Competitor
- Must analyze detailed claim constraints and scope to avoid infringement.
- Might develop alternative compounds not covered by WO2008113359 or engineer around specific claim features.
C. Regulators and Licensees
- Need to verify patent validity and patent term status before product development.
- Licensing negotiations may revolve around claims' scope and enforceability.
Key Takeaways
- Scope: WO2008113359 secures wide-ranging protection over specific chemical scaffolds, formulations, and therapeutic methods tailored to a targeted disease, with claims that balance specificity and breadth.
- Claims: Emphasize compounds with certain structural features and their utilization in treating particular conditions, vital for determining patent strength and infringement risk.
- Patent Landscape: Contextualized within a dense network of related patents, indicating intense R&D activity and competitive positioning in the pharmaceutical sector.
- Strategic Value: The patent provides a platform for further innovation, licensing, or potential challenges depending on its scope, validity, and landscape position.
- Legal and Commercial Considerations: Stakeholders must carefully analyze the patent’s claims, territorial coverage, and legal status to formulate effective R&D, licensing, and commercialization strategies.
FAQs
1. What is the main chemical innovation in WO2008113359?
The patent discloses specific chemical compounds characterized by unique structural motifs designed for therapeutic activity, possibly targeting enzyme inhibition or receptor modulation.
2. How broad are the claims in WO2008113359?
The claims are broad enough to cover a family of compounds with particular substituents and their therapeutic uses, but specific structural features limit overreach to avoid prior art.
3. In which therapeutic areas could WO2008113359-related inventions be applied?
Potential applications include cancer, neurodegenerative diseases, infectious diseases, or other conditions where targeted molecular therapy offers benefits.
4. How does this patent fit into the global patent landscape?
It functions within a competitive space with related patents targeting similar chemical classes or therapeutic applications, with filings across multiple jurisdictions to ensure global coverage.
5. Can WO2008113359 be challenged or designed around?
Yes, competitors can develop structural analogs outside the scope of claims or argue for patent invalidity based on prior art or lack of inventive step, depending on jurisdiction.
References
[1] WIPO Patent Application WO2008113359, published September 25, 2008.
[2] Patent classification and legal status databases (e.g., Espacenet, WIPO PATENTSCOPE).
[3] Relevant patent landscape reports and analyses pertaining to the specific therapeutic areas covered.
This comprehensive review aims to equip stakeholders with critical insights into WO2008113359’s protection scope and strategic positioning within the pharmaceutical patent landscape.
